Gln52 mutations in GNAO1-related disorders and personalized drug discovery

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	100598
Number of pages	2
Journal	Epilepsy and Behavior Reports
Volume	24
DOIs	https://doi.org/10.1016/j.ebr.2023.100598
Publication status	Published - Jan 2023
Externally published	Yes

Keywords

@article{0e6647226a6746509c15aa34b808f352,

title = "Gln52 mutations in GNAO1-related disorders and personalized drug discovery",

keywords = "Animal models, Drug discovery, G protein, GNAO1, Missense mutations, Pediatric encephalopathy",

author = "Katanaev, \{Vladimir L.\}",

year = "2023",

month = jan,

doi = "10.1016/j.ebr.2023.100598",

language = "English",

volume = "24",

journal = "Epilepsy and Behavior Reports",

issn = "2213-3232",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Gln52 mutations in GNAO1-related disorders and personalized drug discovery

AU - Katanaev, Vladimir L.

PY - 2023/1

Y1 - 2023/1

KW - Animal models

KW - Drug discovery

KW - G protein

KW - GNAO1

KW - Missense mutations

KW - Pediatric encephalopathy

UR - https://www.scopus.com/pages/publications/85158129017

U2 - 10.1016/j.ebr.2023.100598

DO - 10.1016/j.ebr.2023.100598

M3 - Letter

AN - SCOPUS:85158129017

SN - 2213-3232

VL - 24

JO - Epilepsy and Behavior Reports

JF - Epilepsy and Behavior Reports

M1 - 100598

ER -